会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Incontinence treatment device
    • 失禁治疗装置
    • US08636644B2
    • 2014-01-28
    • US13589189
    • 2012-08-20
    • Michael M WitzmannDouglas Adelbert Devens, Jr.
    • Michael M WitzmannDouglas Adelbert Devens, Jr.
    • A61F2/00
    • A61F2/0045A61B17/0401A61B2017/00805A61B2017/0464A61F2210/008A61F2210/009A61F2250/0007
    • An incontinence treatment device includes a urethral support and first and second connectors. The urethral support extends between a first end and a second end and has porosity that is configured to allow tissue in-growth through the urethral support. The first connector is attached to the first end of the urethral support and the second connector is attached to the second end of the urethral support. At least one of the first connector and the second connector is a cross-linked polymer connector having a glass transition temperature between 40-70 degrees Celsius. The cross-linked polymer connector has an initial length that is elongated to an implant length that is greater than the initial length. Means for heating the cross-linked polymer connector from an extracorporeal location through intact skin is provided, thereby shortening the cross-linked polymer connector.
    • 失禁治疗装置包括尿道支撑件和第一和第二连接器。 尿道支撑件在第一端和第二端之间延伸并且具有构造成允许组织通过尿道支撑生长的多孔性。 第一连接器连接到尿道支撑件的第一端,第二连接器连接到尿道支撑件的第二端。 第一连接器和第二连接器中的至少一个是玻璃化转变温度在40-70摄氏度之间的交联聚合物连接器。 交联聚合物连接器具有延伸到大于初始长度的植入物长度的初始长度。 提供了通过完整皮肤从体外位置加热交联聚合物连接器的手段,从而缩短了交联聚合物连接器。
    • 8. 发明授权
    • Urethral needle guide device
    • 尿道导针装置
    • US08147397B1
    • 2012-04-03
    • US11565950
    • 2006-12-01
    • Michael M. WitzmannJames D. BrazilDean A. KleinThomas M. Jaeger
    • Michael M. WitzmannJames D. BrazilDean A. KleinThomas M. Jaeger
    • A61M31/00
    • A61B17/3403A61B1/307A61B17/062A61B17/12A61B17/3468A61B2017/0046A61B2017/00561A61B2017/00805A61B2017/3405A61B2017/3407A61F2/0036
    • Methods and devices for treating female urinary incontinence by injecting bulking material into the female urethral wall. Some devices include a handle, an elongate member attached to the handle, and a vacuum generating syringe removably secured to the handle. The elongate member can include a distal portion projecting distally from the handle, the distal portion having a wide proximal region, a narrowing shoulder, and a narrow distal region. The elongate member can include one or more vacuum ports on either side of the shoulder region. The shoulder can include a distally facing needle aperture allowing passage of a needle for injecting bulking agent. A rotatable connection between the elongate member and the handle facilitates rotatable positioning of the elongate member to permit injection of bulking material at different locations around the urethral wall. In use, the urethral tissue can be pulled to conform against the device elongate member by generating a vacuum through the elongate member ports, inserting the needle through the elongate member and needle aperture, and predictably injecting bulking material inside of and along the immobilized urethral wall. The self contained vacuum generator, simple design and wide allowable margin of needle travel allow for use in a practitioner's office.
    • 通过将膨胀材料注入女性尿道壁来治疗女性尿失禁的方法和装置。 一些装置包括手柄,附接到手柄的细长构件和可移除地固定到手柄的真空产生注射器。 细长构件可以包括从手柄向远侧突出的远侧部分,远侧部分具有宽近端区域,变窄的肩部和窄的远端区域。 细长构件可以包括在肩部区域的任一侧上的一个或多个真空口。 肩部可以包括允许通过用于注射填充剂的针的朝向远端的针孔。 细长构件和手柄之间的可旋转连接有利于细长构件的可旋转定位,以允许在尿道壁周围的不同位置处注射膨胀材料。 在使用中,尿道组织可以被拉动以通过细长构件端口产生真空而将其穿过细长构件和针孔插入穿过装置细长构件,并且可预测地在固定的尿道壁内部和内部注入膨胀材料 。 自包含真空发生器,设计简单,允许的行程容许宽度允许在医生办公室使用。
    • 10. 发明申请
    • INCONTINENCE TREATMENT DEVICE
    • 不良治疗装置
    • US20120310039A1
    • 2012-12-06
    • US13589189
    • 2012-08-20
    • Michael M. WitzmannDouglas Adelbert Devens, JR.
    • Michael M. WitzmannDouglas Adelbert Devens, JR.
    • A61F2/04
    • A61F2/0045A61B17/0401A61B2017/00805A61B2017/0464A61F2210/008A61F2210/009A61F2250/0007
    • An incontinence treatment device includes a urethral support and first and second connectors. The urethral support extends between a first end and a second end and has porosity that is configured to allow tissue in-growth through the urethral support. The first connector is attached to the first end of the urethral support and the second connector is attached to the second end of the urethral support. At least one of the first connector and the second connector is a cross-linked polymer connector having a glass transition temperature between 40-70 degrees Celsius. The cross-linked polymer connector has an initial length that is elongated to an implant length that is greater than the initial length. Means for heating the cross-linked polymer connector from an extracorporeal location through intact skin is provided, thereby shortening the cross-linked polymer connector.
    • 失禁治疗装置包括尿道支撑件和第一和第二连接器。 尿道支撑件在第一端和第二端之间延伸并且具有构造成允许组织通过尿道支撑生长的多孔性。 第一连接器连接到尿道支撑件的第一端,第二连接器连接到尿道支撑件的第二端。 第一连接器和第二连接器中的至少一个是玻璃化转变温度在40-70摄氏度之间的交联聚合物连接器。 交联聚合物连接器具有延伸到大于初始长度的植入物长度的初始长度。 提供了通过完整皮肤从体外位置加热交联聚合物连接器的手段,从而缩短了交联聚合物连接器。